Will the pharmaceutical industry take over the CBD infused products market? Could CBG could be the next CBD-like cannabinoid consumers look for? Who in Oregon is leading innovation in the “craft hemp” category? All discussed with our guest Shango Los, consultant, speaker and podcast host with many years experience in cannabis, business and the science of it all.
The 2018 Farm Bill has passed, Hemp CBD is now legal, but the future results may surprise you! Our guest today is David Heldreth, Founder of Panacea Plant Sciences and Content Manager for True Terpenes. We discuss negatives of the Farm Bill and how SMBs might be pushed out in preference for the pharmaceutical model. We also discuss a cannabis growth additive David has developed to increase terpene and cannabinoid potency by engaging defense mechanisms in the cannabis plant.
What can we do to prevent the Farm Bill outcome discussed in episode? The Department of Human and Health Services (HHS) is the cabinet department that oversees the FDA. Contact HHS secretary (Alex M. Azar II) who can call for the hearings and other actions needed discussed in episode. LINK for the secretary of HHS
Back with Emma Chasen from Eminent Consulting for another Science of Cannabis podcast. This episode focuses on the 2018 Farm Bill, how you can tell the difference between indoor and outdoor cannabis, sales techniques for budtenders and how cultured high-purity cannabinoids from yeast could disrupt the industry!